Compare CCOI & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCOI | ABCL |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 951.9M | 1.1B |
| IPO Year | 2002 | 2020 |
| Metric | CCOI | ABCL |
|---|---|---|
| Price | $24.43 | $4.19 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $29.11 | $8.40 |
| AVG Volume (30 Days) | 817.7K | ★ 4.0M |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.32% | N/A |
| EPS Growth | ★ 11.21 | 10.91 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $975,766,000.00 | $75,128,000.00 |
| Revenue This Year | $11.76 | N/A |
| Revenue Next Year | $6.09 | $21.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 160.56 |
| 52 Week Low | $15.96 | $1.94 |
| 52 Week High | $56.89 | $6.52 |
| Indicator | CCOI | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 62.86 | 69.78 |
| Support Level | $22.31 | $3.91 |
| Resistance Level | $25.51 | $4.76 |
| Average True Range (ATR) | 1.33 | 0.21 |
| MACD | 0.30 | 0.05 |
| Stochastic Oscillator | 82.69 | 81.68 |
Cogent carries over one-fifth of the world's internet traffic on its network, providing high-capacity services to businesses. Cogent's corporate customers are in high-rise office buildings, where the firm provides two types of connections: dedicated internet access, which connects them to the internet, and virtual private networking, which offers an internal network for employees in different locations. Cogent's corporate customers are exclusively in North America and account for nearly half of the firm's revenue. Cogent's netcentric customers include internet service providers and content providers, to which Cogent provides internet transit. They hand traffic to Cogent in data centers and rely on Cogent to deliver it. About half of netcentric revenue is from outside the US.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.